11
Oct
Cilcare is proud to announce that its breakthrough compound, CIL001, has been named the winner in the Therapeutics category at the 5th Annual Hearing Technology Innovator Awards™, hosted by Hearing Health & Technology Matters.
This prestigious recognition celebrates the innovative potential of CIL001, a first-in-class drug candidate designed to treat cochlear synaptopathy, a leading cause of age-related hearing loss, often referred to as “hidden hearing loss.” This condition affects millions worldwide and is characterized by difficulty hearing in noisy environments—an issue for which there is currently...